ÌÇÐÄvlog

Object moved to here.

Hemolytic Anemia and Somatic Cell Dysfunction in Severe Hypophosphatemia | JAMA Internal Medicine | ÌÇÐÄvlog

ÌÇÐÄvlog

[Skip to Navigation]
Sign In
Article
´¡³Ü²µ³Ü²õ³ÙÌý1974

Hemolytic Anemia and Somatic Cell Dysfunction in Severe Hypophosphatemia

Author Affiliations

San Francisco

From the Medical and Pediatric Services, San Francisco General Hospital, and the departments of medicine and pediatrics, University of California, San Francisco.

Arch Intern Med. 1974;134(2):360-364. doi:10.1001/archinte.1974.00320200170025
Abstract

The syndrome of phosphorus depletion became widely recognized following the description by Lotz et al1 of hypophosphatemia in patients undergoing prolonged therapy with antacids. Since their description, others have reported similar cases of hypophosphatemia due to therapy with antacids in patients with uremia,2,3 in patients receiving intravenous hyperalimentation without phosphorus supplementation,4-6 and in the debilitated and starved patient.7 The clinical and laboratory findings in these patients included confusion, weakness, anorexia, malaise, paresthesias,1-3,6,7 electroencephalographic and electromyographic changes,3 altered hemoglobin-oxygen affinity,2,4,5 changes in the concentrations of erythrocyte organic phosphates and glycolytic intermediates,2,4,5,7 and, more recently, hemolytic anemia with rigid red blood cells (RBC).7 Metabolic studies in a severely hypophosphatemic patient are presented herein to support the concept that a generalized inhibition of glycolysis and glycogenolysis with subsequent depletion of energy stores may underly the manifestations of severe hypophosphatemia.

Patient SummaryÌý A 47-year-old chronic

×